ARTICLE | Clinical News
BJI InoPlex regulatory update
February 9, 2015 8:00 AM UTC
Diaxonhit received CE Mark approval for BJI InoPlex test to diagnose prosthetic bone and joint infections. The company said it will launch the non-invasive multi-parameter serologic test in France on ...